InvestorsHub Logo
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

Re: stockaesthetics post# 77630

Saturday, 10/08/2016 8:40:13 PM

Saturday, October 08, 2016 8:40:13 PM

Post# of 463667
The truth is biotech is all about the scientific potential of a company's pipeline. Most retail "investors" and traders do damn little DD on the company's compounds. Don't even go to the company's website and read the news releases and publications. They don't know squat about biology, biochem, pharmacology, physiology, anatomy, etc. So, they are ignorant and thus susceptible to falling prey to the BS put out by Adam Feuerstein, Jean Fontenewww, and the other hedge fund mouthpieces. Even if I believed Feuerstein was sincere, which I do not for one second, why would I listen to him talking about the science of drugs or drug trial results and design? He has a lib arts degree and has been nothing more than a biotech pundit as of late. Feuerstein cited a Dr's opinion on 273 last year. That Dr didn't break down the science, just compared it to being as effective as coffee for treating Alzheimers. That noname "Dr" hasn't practiced medicine in years and is working in Europe doing PC repair and tech support for $10/hr. And that is Feuerstein's "go to" medical "expert". Please. Probably some guy with a MD that is broke, strung out on drugs that the hedge funds could pay to spew BS.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News